Board Member
MiNK Therapeutics, Inc. (INKT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Jennifer Buell is recorded as CEO and Board Member at MiNK Therapeutics, Inc. (INKT). The proxy statement of MiNK Therapeutics, Inc. reports total compensation of $2,087,881 for Jennifer Buell in fiscal 2025, including a base salary of $448,000. Disclosed compensation is on record for 6 fiscal years. Jennifer Buell has spoken on 11 earnings calls across 1 company, most recently for MiNK Therapeutics, Inc. on August 13, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2022-06-08–present
Recorded roles and call appearances connecting this person to public companies.
CEO, Board Member
2022-06-08–present
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | MiNK Therapeutics, Inc. (INKT) | President and Chief Executive Officer | $448,000 | $2,087,881 |
| 2024 | MiNK Therapeutics, Inc. (INKT) | President and Chief Executive Officer | $448,000 | $1,078,686 |
| 2023 | MiNK Therapeutics, Inc. (INKT) | President and Chief Executive Officer | $451,048 | $2,807,439 |
| 2022 | MiNK Therapeutics, Inc. (INKT) | President and Chief Executive Officer | $424,298 | $3,871,880 |
| 2021 | MiNK Therapeutics, Inc. (INKT) | President and Chief Executive Officer | $232,539 | $3,890,774 |
| 2020 | MiNK Therapeutics, Inc. (INKT) | President and Chief Executive Officer | — | $917 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
